Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC8 | Q9BY41 | 14/20 | 1.00 |
| ▸ | HDAC3 | O15379 | 10/20 | 1.00 |
| ▸ | HDAC6 | Q9UBN7 | 10/20 | 1.00 |
| ▸ | HDAC4 | P56524 | 9/20 | 1.00 |
| ▸ | HDAC1 | Q13547 | 9/20 | 1.00 |
| ▸ | HDAC7 | Q8WUI4 | 9/20 | 1.00 |
| ▸ | HDAC2 | Q92769 | 9/20 | 1.00 |
| ▸ | HDAC10 | Q969S8 | 9/20 | 1.00 |
| ▸ | HDAC11 | Q96DB2 | 9/20 | 1.00 |
| ▸ | HDAC9 | Q9UKV0 | 9/20 | 1.00 |
| ▸ | HDAC5 | Q9UQL6 | 9/20 | 1.00 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.60 |
| ▸ | QPCTL | Q9NXS2 | 1/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.49 |
| ▸ | LIG1 | P18858 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29763455 | 1.00 | HDAC8 (1.00) | HDAC8HDAC3HDAC6HDAC4HDAC1 | |
| SCHEMBL1164962 | 0.73 | HDAC6 (0.78) | HDAC8HDAC3HDAC6HDAC4HDAC1 | |
| SCHEMBL1164730 | 0.71 | HDAC6 (0.74) | HDAC8HDAC3HDAC6HDAC4HDAC1 | |
| SCHEMBL27340659 | 0.70 | HDAC8 (1.00) | HDAC8HDAC3HDAC6HDAC4HDAC1 | |
| SCHEMBL19708171 | 0.70 | MEN1 (0.78) | HDAC8HDAC3HDAC6HDAC4HDAC1 | |
| SCHEMBL10363097 | 0.70 | HDAC8 (1.00) | HDAC8HDAC3HDAC6HDAC1HDAC7 | |
| SCHEMBL2397994 | 0.70 | QPCTL (0.83) | HDAC8HDAC3HDAC6HDAC4HDAC1 | |
| SCHEMBL14233963 | 0.70 | UCHL5 (0.58) | HDAC8HDAC3HDAC6HDAC4HDAC1 | |
| SCHEMBL8976870 | 0.69 | HDAC1 (0.69) | HDAC8HDAC3HDAC6HDAC4HDAC1 | |
| SCHEMBL28847848 | 0.69 | HDAC8 (0.53) | HDAC8HDAC3HDAC6HDAC4HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115124043-B | Silica particles and method for producing same | 富士胶片商业创新有限公司 | 2026-05-12 | — | — | CN | disclosed |
| EP-4403519-A1 | SILICA PARTICLE, TONER FOR DEVELOPING ELECTROSTATIC CHARGE IMAGE, AND ELECTROSTATIC CHARGE IMAGE DEVELOPER | FUJIFILM Business Innovation Corp. (JP) | 2024-07-24 | — | — | EP | disclosed |
| US-20240118642-A1 | TONER FOR ELECTROSTATIC IMAGE DEVELOPMENT, ELECTROSTATIC IMAGE DEVELOPER, TONER CARTRIDGE, PROCESS CARTRIDGE, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD | FUJIFILM BUSINESS INNOVATION CORP. (JP) | 2024-04-11 | — | — | US | disclosed |
| EP-4343439-A1 | ELECTROSTATIC CHARGE IMAGE DEVELOPING TONER, ELECTROSTATIC CHARGE IMAGE DEVELOPER, TONER CARTRIDGE, PROCESS CARTRIDGE, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD | FUJIFILM Business Innovation Corp. (JP) | 2024-03-27 | — | — | EP | disclosed |
| CN-117742100-A | Toner for developing electrostatic latent image, electrostatic latent image developer, toner cartridge, process cartridge, image forming apparatus, and image forming method | 富士胶片商业创新有限公司 | 2024-03-22 | — | — | CN | disclosed |
| CN-117742098-A | Toner for developing electrostatic latent image, electrostatic latent image developer, toner cartridge, process cartridge, image forming apparatus, and image forming method | 富士胶片商业创新有限公司 | 2024-03-22 | — | — | CN | disclosed |
| CN-117742103-A | Silica particles, toner, developer, cartridge, image forming apparatus, and image forming method | 富士胶片商业创新有限公司 | 2024-03-22 | — | — | CN | disclosed |
| CN-117742104-A | Silica particles, toner, developer, cartridge, image forming apparatus, and image forming method | 富士胶片商业创新有限公司 | 2024-03-22 | — | — | CN | disclosed |
| CN-117742097-A | Toner for developing electrostatic latent image, electrostatic latent image developer, toner cartridge, process cartridge, image forming apparatus, and image forming method | 富士胶片商业创新有限公司 | 2024-03-22 | — | — | CN | disclosed |
| CN-117742102-A | Silica particles, toner, electrostatic latent image developer, toner cartridge, process cartridge, image forming apparatus, and image forming method | 富士胶片商业创新有限公司 | 2024-03-22 | — | — | CN | disclosed |
| US-20210283265-A1 | METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE | Design Therapeutics, Inc. | 2021-09-16 | — | — | US | disclosed |
| US-20210284629-A1 | METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE | Design Therapeutics, Inc. | 2021-09-16 | — | — | US | disclosed |
| US-20210238226-A1 | METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE | Design Therapeutics, Inc. | 2021-08-05 | — | — | US | disclosed |
| US-20210228723-A1 | METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE | Design Therapeutics, Inc. | 2021-07-29 | — | — | US | disclosed |
| US-20180051314-A1 | COMPOUNDS, SUBSTRATES AND METHODS RELATED TO HISTONE DEACETYLASES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2018-02-22 | — | — | US | disclosed |
| US-20180051314-A1 | COMPOUNDS, SUBSTRATES AND METHODS RELATED TO HISTONE DEACETYLASES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2018-02-22 | — | — | US | disclosed |
| US-9745613-B2 | Compounds, substrates and methods related to histone deacetylases | THE BROAD INSTITUTE, INC. (US) | 2017-08-29 | — | — | US | disclosed |
| US-9745613-B2 | Compounds, substrates and methods related to histone deacetylases | THE BROAD INSTITUTE, INC. (US) | 2017-08-29 | — | — | US | disclosed |
| US-20160060679-A1 | COMPOUNDS, SUBSTRATES AND METHODS RELATED TO HISTONE DEACETYLASES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2016-03-03 | — | — | US | disclosed |
| US-20160060679-A1 | COMPOUNDS, SUBSTRATES AND METHODS RELATED TO HISTONE DEACETYLASES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2016-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210238226-A1 | METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE | ATXN2L, ATXN2, ATXN10 | HDAC8 2038/4885HDAC3 1962/4885HDAC6 898/4885 |
| US-20180051314-A1 | COMPOUNDS, SUBSTRATES AND METHODS RELATED TO HISTONE DEACETYLASES | HDAC1, HDAC11, HDAC10 | HDAC8 18/4885HDAC3 4/4885HDAC6 16/4885 |
| US-20210283265-A1 | METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE | NEDD4, CBL, UBQLN2 | HDAC8 1533/4885HDAC3 3028/4885HDAC6 1477/4885 |
| US-20210228723-A1 | METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE | ZFX, F13B, GRN | HDAC8 384/4885HDAC3 1324/4885HDAC6 645/4885 |
| US-20160060679-A1 | COMPOUNDS, SUBSTRATES AND METHODS RELATED TO HISTONE DEACETYLASES | HDAC1, HDAC11, HDAC10 | HDAC8 20/4885HDAC3 4/4885HDAC6 18/4885 |
| US-20210284629-A1 | METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE | NEDD4, UBQLN2, UBTF | HDAC8 761/4885HDAC3 1673/4885HDAC6 357/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.